Trinity Biotech ADR buy StockNews.com
Start price
17.06.23
/
50%
€0.91
Target price
17.06.24
-
Performance (%)
-53.41%
End price
18.06.24
-
Summary
This prediction is currently being closed. Massive losses of -53.41% have been the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Trinity Biotech ADR where he still thinks Trinity Biotech ADR is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Trinity Biotech ADR | - | - | - |
iShares Core DAX® | 0.786% | -0.427% | 17.458% |
iShares Nasdaq 100 | 2.297% | 7.331% | 38.189% |
iShares Nikkei 225® | 3.076% | 3.279% | 13.174% |
iShares S&P 500 | 0.902% | 3.970% | 29.787% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten